Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity

Details 詳細情報について

• CRID

  1363388843317662464

• DOI

  10.1007/s00281-006-0057-9

• ISSN

  14322196

  03444325

• Web Site

  http://link.springer.com/content/pdf/10.1007/s00281-006-0057-9.pdf

  http://link.springer.com/article/10.1007/s00281-006-0057-9/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s00281-006-0057-9

• Data Source

  • Crossref